NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 149 filers reported holding NEWLINK GENETICS CORP in Q2 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FT Options LLC | 21,900 | $1,292,000 | 1.11% |
TIVERTON ASSET MANAGEMENT LLC | 288,807 | $18,215,000 | 0.77% |
Knoll Capital Management, LLC | 102,437 | $1,153,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 460,146 | $5,181,000 | 0.36% |
WALL STREET ASSOCIATES | 79,000 | $890,000 | 0.36% |
Endurant Capital Management LP | 62,491 | $704,000 | 0.24% |
FT Options LLC | 21,903 | $247,000 | 0.21% |
Virtus ETF Advisers LLC | 24,463 | $275,000 | 0.20% |
Orbimed Advisors | 1,581,506 | $17,808,000 | 0.19% |
HAP Trading, LLC | 227,728 | $2,564,000 | 0.15% |